Srdjan R. Stankovic
Net Worth

Last updated:

What is Srdjan R. Stankovic net worth?

The estimated net worth of Dr. Srdjan R. Stankovic is at least $22,385,658 as of 21 Nov 2022. He owns shares worth $1,529,013 as insider, has earned $14,136,645 from insider trading and has received compensation worth at least $6,720,000 in ACADIA Pharmaceuticals Inc..

What is the salary of Srdjan R. Stankovic?

Dr. Srdjan R. Stankovic salary is $1,120,000 per year as Pres in ACADIA Pharmaceuticals Inc..

How old is Srdjan R. Stankovic?

Dr. Srdjan R. Stankovic is 68 years old, born in 1957.

What stocks does Srdjan R. Stankovic currently own?

As insider, Dr. Srdjan R. Stankovic owns shares in one company:

Company Title Shares Price per share Total value
ACADIA Pharmaceuticals Inc. (ACAD) Pres 61,234 $24.97 $1,529,013

What does ACADIA Pharmaceuticals Inc. do?

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

ACAD logo
ACAD
ACADIA Pharmaceuticals Inc.
$24.97

Srdjan R. Stankovic insider trading

ACADIA Pharmaceuticals Inc.

Dr. Srdjan R. Stankovic has made 23 insider trades between 2019-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 100,000 units of ACAD stock on 20 Apr 2020. As of 21 Nov 2022 he still owns at least 61,234 units of ACAD stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 6,250 N/A N/A
Sale
Common Stock 1,847 $15.07 $27,834
Option
Common Stock 6,250 N/A N/A
Option
Common Stock 2,969 N/A N/A
Sale
Common Stock 1,326 $15.81 $20,964
Option
Restricted Stock Units 2,969 N/A N/A
Sale
Common Stock 2,865 $18.18 $52,091
Option
Restricted Stock Units 9,616 N/A N/A
Option
Common Stock 9,616 N/A N/A
Option
Restricted Stock Units 4,919 N/A N/A
Sale
Common Stock 1,501 $23.8 $35,724
Option
Common Stock 4,919 N/A N/A
Option
Restricted Stock Units 5,444 N/A N/A
Option
Common Stock 5,444 N/A N/A
Sale
Common Stock 1,937 $23.05 $44,648
Sale
Common Stock 2,803 $19.01 $53,285
Option
Restricted Stock Units 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Sale
Common Stock 1,338 $17.41 $23,295
Option
Restricted Stock Units 2,969 N/A N/A
Option
Common Stock 2,969 N/A N/A
Sale
Common Stock 4,230 N/A N/A
Option
Common Stock 9,615 N/A N/A
Option
Restricted Stock Units 9,615 N/A N/A
Sale
Common Stock 8,429 $50.61 $426,592
Sale
Common Stock 700 N/A N/A
Option
Common Stock 700 N/A N/A
Option
Stock Option (Right to Buy) 700 N/A N/A
Option
Common Stock 29,733 $25.07 $745,317
Option
Stock Option (Right to Buy) 29,733 $25.07 $745,317
Option
Common Stock 29,733 $25.07 $745,317
Option
Stock Option (Right to Buy) 29,733 $25.07 $745,317
Sale
Common Stock 29,733 $55.22 $1,641,827
Sale
Common Stock 61,619 $55.12 $3,396,193
Option
Common Stock 61,619 $55.12 $3,396,193
Option
Common Stock 5,444 $35.8 $194,895
Sale
Common Stock 1,725 $53.34 $92,012
Option
Restricted Stock Units 5,444 $35.8 $194,895
Option
Stock Option (Right to Buy) 61,619 $55.12 $3,396,193
Sale
Common Stock 2,728 $53.5 $145,948
Option
Restricted Stock Units 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Sale
Common Stock 1,297 $42.56 $55,200
Option
Common Stock 2,969 N/A N/A
Option
Restricted Stock Units 2,969 N/A N/A
Sale
Common Stock 16,452 $50.12 $824,508
Option
Employee Stock Option (Right to Buy) 16,452 $50.12 $824,508
Option
Common Stock 16,452 $50.12 $824,508
Sale
Common Stock 65,843 $50.01 $3,292,743
Option
Common Stock 65,843 $12.7 $836,206
Option
Employee Stock Option (Right to Buy) 65,843 $12.7 $836,206
Sale
Common Stock 4,308 $49.21 $211,997
Option
Restricted Stock Units 9,615 N/A N/A
Option
Common Stock 9,615 N/A N/A
Sale
Common Stock 18,949 $50.07 $948,739
Option
Common Stock 18,949 $20.47 $387,791
Option
Common Stock 18,949 $10.64 $201,617
Option
Employee Stock Option (Right to Buy) 18,949 $10.64 $201,617
Option
Employee Stock Option (Right to Buy) 18,949 $20.47 $387,791
Sale
Common Stock 54,019 $50.02 $2,701,922
Option
Common Stock 54,019 $19.82 $1,070,386
Option
Employee Stock Option (Right to Buy) 54,019 $19.82 $1,070,386
Option
Employee Stock Option (Right to Buy) 100,000 N/A N/A
Sale
Common Stock 100,000 N/A N/A
Option
Common Stock 100,000 N/A N/A
Sale
Common Stock 2,160 $46.41 $100,246
Option
Restricted Stock Units 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Option
Restricted Stock Units 2,968 N/A N/A
Option
Common Stock 2,968 N/A N/A
Sale
Common Stock 1,031 $39.65 $40,879

ACADIA Pharmaceuticals key executives

ACADIA Pharmaceuticals Inc. executives and other stock owners filed with the SEC: